Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors.

Stucci LS, D'Oronzo S, Tucci M, Macerollo A, Ribero S, Spagnolo F, Marra E, Picasso V, Orgiano L, Marconcini R, De Rosa F, Di Guardo L, Galli G, Gandini S, Palmirotta R, Palmieri G, Queirolo P, Silvestris F; Italian Melanoma Intergroup (IMI).

Cancer Treat Rev. 2018 May 31;69:21-28. doi: 10.1016/j.ctrv.2018.05.016. [Epub ahead of print] Review.

PMID:
29864718
2.

SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.

Palmirotta R, Carella C, Silvestris E, Cives M, Stucci SL, Tucci M, Lovero D, Silvestris F.

Oncotarget. 2018 May 18;9(38):25355-25382. doi: 10.18632/oncotarget.25256. eCollection 2018 May 18. Review.

3.

Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels.

Severino P, D'Amato A, Netti L, Pucci M, De Marchis M, Palmirotta R, Volterrani M, Mancone M, Fedele F.

Int J Mol Sci. 2018 Mar 10;19(3). pii: E802. doi: 10.3390/ijms19030802. Review.

4.

Genetic bases of the nutritional approach to migraine.

De Marchis ML, Guadagni F, Silvestris E, Lovero D, Della-Morte D, Ferroni P, Barbanti P, Palmirotta R.

Crit Rev Food Sci Nutr. 2018 Mar 8:1-13. doi: 10.1080/10408398.2018.1450215. [Epub ahead of print]

PMID:
29517920
5.

Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family.

Palmirotta R, Lovero D, Stucci LS, Silvestris E, Quaresmini D, Cardascia A, Silvestris F.

Int J Mol Sci. 2018 Jan 18;19(1). pii: E285. doi: 10.3390/ijms19010285.

6.

Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management.

Stucci S, Palmirotta R, Passarelli A, Silvestris E, Argentiero A, Lanotte L, Acquafredda S, Todisco A, Silvestris F.

Oncol Lett. 2017 Nov;14(5):5671-5680. doi: 10.3892/ol.2017.6919. Epub 2017 Sep 8.

7.

Redox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions.

Ferroni P, Barbanti P, Della-Morte D, Palmirotta R, Jirillo E, Guadagni F.

Antioxid Redox Signal. 2018 Apr 20;28(12):1144-1183. doi: 10.1089/ars.2017.7260. Epub 2017 Nov 21.

PMID:
28990418
8.

Procoagulant imbalance in premenopausal women with chronic migraine.

Ferroni P, Barbanti P, Aurilia C, Egeo G, Fofi L, La Farina F, Valente MG, De Marchis ML, Spila A, Palmirotta R, Della-Morte D, Guadagni F.

Neurology. 2017 Oct 3;89(14):1525-1527. doi: 10.1212/WNL.0000000000004435. Epub 2017 Aug 25. No abstract available.

PMID:
28842452
9.

Ovarian cancer: Novel molecular aspects for clinical assessment.

Palmirotta R, Silvestris E, D'Oronzo S, Cardascia A, Silvestris F.

Crit Rev Oncol Hematol. 2017 Sep;117:12-29. doi: 10.1016/j.critrevonc.2017.06.007. Epub 2017 Jun 17. Review.

PMID:
28807232
10.

Desmoid Tumors in Familial Adenomatous Polyposis.

DE Marchis ML, Tonelli F, Quaresmini D, Lovero D, Della-Morte D, Silvestris F, Guadagni F, Palmirotta R.

Anticancer Res. 2017 Jul;37(7):3357-3366. Review.

PMID:
28668823
11.

Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).

Palmirotta R, Lovero D, Silvestris E, Felici C, Quaresmini D, Cafforio P, Silvestris F.

Cancer Genomics Proteomics. 2017 May-Jun;14(3):173-179.

12.

Characterization of a rare nonpathogenic sequence variant (c.1905C>T) of the dihydropyrimidine dehydrogenase gene (DPYD).

Palmirotta R, Lovero D, Silvestris E, Carella C, Felici C, Quaresmini D, Cafforio P, Silvestris F.

Int J Biol Markers. 2017 Jul 24;32(3):e357-e360. doi: 10.5301/ijbm.5000260.

PMID:
28430339
13.

Sex-Genetic Interaction in the Risk for Cerebrovascular Disease.

Pastore D, Pacifici F, Capuani B, Palmirotta R, Dong C, Coppola A, Abete P, Roselli M, Sbraccia P, Guadagni F, Lauro D, Rundek T, Della-Morte D.

Curr Med Chem. 2017;24(24):2687-2699. doi: 10.2174/0929867324666170417100318. Review.

PMID:
28413964
14.

O039. Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana.

Barbanti P, Palmirotta R, De Marchis ML, Ialongo C, Egeo G, Aurilia C, Fofi L, Piroso S, Fratangeli F, Valente MG, Guadagni F.

J Headache Pain. 2015 Dec;16(Suppl 1):A120. doi: 10.1186/1129-2377-16-S1-A120. No abstract available.

15.

ALK gene alterations in cancer: biological aspects and therapeutic implications.

Palmirotta R, Quaresmini D, Lovero D, Silvestris F.

Pharmacogenomics. 2017 Feb;18(3):277-292. doi: 10.2217/pgs-2016-0166. Epub 2017 Jan 23.

PMID:
28112990
16.

Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development.

Barbanti P, Aurilia C, Egeo G, Fofi L, Palmirotta R.

Expert Opin Investig Drugs. 2017 Mar;26(3):269-277. doi: 10.1080/13543784.2017.1283404. Epub 2017 Feb 1. Review.

PMID:
28103158
17.

[Genomics of lung adenocarcinoma: pathogenetic significance and clinical applications.]

Palmirotta R, Acquafredda S, Argentiero A, Carella C, Lanotte L, Pappagallo N, Quaresmini D, Silvestris F.

Recenti Prog Med. 2016 Dec;107(12):652-672. doi: 10.1701/2502.26236. Review. Italian.

PMID:
27997009
18.

Characterization of a Rare Nonpathogenic Methylenetetrahydrofolatereductase (MTHFR) Gene Mutation p.Lys215del in a Southern Italian family.

Palmirotta R, Lovero D, Silvestris E, Simone V, Lanotte L, Quaresmini D, Silvestris F.

Hum Mutat. 2017 Jan;38(1):120-121. doi: 10.1002/humu.23132. Epub 2016 Oct 21. No abstract available.

PMID:
27768236
19.

The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators.

Capuani B, Pacifici F, Pastore D, Palmirotta R, Donadel G, Arriga R, Bellia A, Di Daniele N, Rogliani P, Abete P, Sbraccia P, Guadagni F, Lauro D, Della-Morte D.

Pharmacol Res. 2016 Sep;111:659-667. doi: 10.1016/j.phrs.2016.07.029. Epub 2016 Jul 25. Review.

PMID:
27461137
20.

Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition.

Palmirotta R, Cives M, Della-Morte D, Capuani B, Lauro D, Guadagni F, Silvestris F.

Oxid Med Cell Longev. 2016;2016:3031459. doi: 10.1155/2016/3031459. Epub 2016 Jun 9. Review.

21.

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.

Rizzo FM, Palmirotta R, Marzullo A, Resta N, Cives M, Tucci M, Silvestris F.

BMC Cancer. 2016 Feb 11;16:87. doi: 10.1186/s12885-016-2111-x.

22.

Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle.

Riondino S, Ferroni P, Spila A, Alessandroni J, D'Alessandro R, Formica V, Della-Morte D, Palmirotta R, Nanni U, Roselli M, Guadagni F.

Cancer Genomics Proteomics. 2015 Nov-Dec;12(6):291-9. Review.

PMID:
26543078
23.

VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients.

Ferroni P, Palmirotta R, Riondino S, De Marchis ML, Nardecchia A, Formica V, Guadagni F, Roselli M.

Thromb Haemost. 2016 Jan;115(1):143-51. doi: 10.1160/TH15-03-0259. Epub 2015 Sep 3.

PMID:
26336029
24.

Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases.

Lauro D, Pastore D, Capuani B, Pacifici F, Palmirotta R, Abete P, Roselli M, Bellia A, Federici M, Di Daniele N, Sbraccia P, Guadagni F, Lauro R, Della-Morte D.

Curr Med Chem. 2015;22(33):3765-88. Review.

PMID:
26264924
25.

Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress.

Ferroni P, Riondino S, Buonomo O, Palmirotta R, Guadagni F, Roselli M.

Oxid Med Cell Longev. 2015;2015:183928. doi: 10.1155/2015/183928. Epub 2015 Jun 11. Review.

26.

Comparison of therapy with Ticagrelor, Prasugrel or high Clopidogrel dose in PCI patients with high on treatment platelet reactivity and genotype variation. TRIPLETE RESET trial.

Sardella G, Calcagno S, Mancone M, Lucisano L, Pennacchi M, Stio RE, Placentino F, Di Roma A, Cavallo E, Palmirotta R, Guadagni F, Fedele F.

Int J Cardiol. 2015 Sep 1;194:60-2. doi: 10.1016/j.ijcard.2015.05.085. Epub 2015 May 15. No abstract available.

PMID:
26011265
27.

Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study.

De Marchis ML, Barbanti P, Palmirotta R, Egeo G, Aurilia C, Fofi L, Piroso S, Ialongo C, Della-Morte D, D'Andrea G, Ferroni P, Guadagni F.

J Headache Pain. 2015;16:520. doi: 10.1186/s10194-015-0520-x. Epub 2015 Apr 30.

28.

Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.

Della-Morte D, Riondino S, Ferroni P, Palmirotta R, Pastore D, Lauro D, Guadagni F, Roselli M.

Pharmacogenomics. 2015 Jan;16(1):61-78. doi: 10.2217/pgs.14.136. Review.

PMID:
25560471
29.

Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.

Della-Morte D, Palmirotta R, Rehni AK, Pastore D, Capuani B, Pacifici F, De Marchis ML, Dave KR, Bellia A, Fogliame G, Ferroni P, Donadel G, Cacciatore F, Abete P, Dong C, Pileggi A, Roselli M, Ricordi C, Sbraccia P, Guadagni F, Rundek T, Lauro D.

Pharmacogenomics. 2014 Dec;15(16):2063-82. doi: 10.2217/pgs.14.162. Review.

30.

Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine.

Palmirotta R, Barbanti P, Ialongo C, De Marchis ML, Alessandroni J, Egeo G, Aurilia C, Fofi L, Valente MG, Ferroni P, Della-Morte D, Guadagni F.

DNA Cell Biol. 2015 Mar;34(3):208-12. doi: 10.1089/dna.2014.2534. Epub 2014 Dec 10.

31.

Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?

Palmirotta R, Barbanti P, De Marchis ML, Egeo G, Aurilia C, Fofi L, Ialongo C, Valente MG, Ferroni P, Della-Morte D, Guadagni F.

Antioxid Redox Signal. 2015 Jan 20;22(3):275-9. doi: 10.1089/ars.2014.6069. Epub 2014 Nov 11.

32.

Diagnostic procedures for paraffin-embedded tissues analysis in pharmacogenomic studies.

Palmirotta R, De Marchis ML, Ludovici G, Ferroni P, Abete P, Guadagni F, Della-Morte D.

Methods Mol Biol. 2014;1175:45-65. doi: 10.1007/978-1-4939-0956-8_4.

PMID:
25150866
33.

Obesity and colorectal cancer: role of adipokines in tumor initiation and progression.

Riondino S, Roselli M, Palmirotta R, Della-Morte D, Ferroni P, Guadagni F.

World J Gastroenterol. 2014 May 14;20(18):5177-90. doi: 10.3748/wjg.v20.i18.5177. Review.

34.

Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome.

Ferroni P, Roselli M, Portarena I, Formica V, Riondino S, LA Farina F, Costarelli L, Melino A, Massimiani G, Cavaliere F, Palmirotta R, Guadagni F.

Anticancer Res. 2014 Mar;34(3):1153-61.

PMID:
24596353
35.

Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study.

Palmirotta R, Barbanti P, Ludovici G, De Marchis ML, Ialongo C, Egeo G, Aurilia C, Fofi L, Abete P, Spila A, Ferroni P, Della-Morte D, Guadagni F.

Pharmacogenomics. 2014 Feb;15(2):147-55. doi: 10.2217/pgs.13.186.

PMID:
24444405
36.

Age-related reduction of cerebral ischemic preconditioning: myth or reality?

Della-Morte D, Cacciatore F, Salsano E, Pirozzi G, Del Genio MT, D'Antonio I, Gargiulo G, Palmirotta R, Guadagni F, Rundek T, Abete P.

Clin Interv Aging. 2013;8:1055-61. doi: 10.2147/CIA.S47462. Epub 2013 Aug 8. Review.

37.

Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease.

Fedele F, Mancone M, Chilian WM, Severino P, Canali E, Logan S, De Marchis ML, Volterrani M, Palmirotta R, Guadagni F.

Basic Res Cardiol. 2013 Nov;108(6):387. doi: 10.1007/s00395-013-0387-4. Epub 2013 Sep 26.

38.

An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies.

Palmirotta R, Leone B, De Marchis ML, Ludovici G, Savonarola A, Ferroni P, Rundek T, Roselli M, Della-Morte D, Guadagni F.

Blood Coagul Fibrinolysis. 2013 Oct;24(7):784-6. doi: 10.1097/MBC.0b013e3283642d5b. No abstract available.

PMID:
24064904
39.

A reliable and reproducible technique for DNA fingerprinting in biorepositories: a pilot study from BioBIM.

Palmirotta R, De Marchis ML, Ludovici G, Ialongo C, Leone B, Lopez N, Valente MG, Spila A, Ferroni P, Della-Morte D, Guadagni F.

Int J Biol Markers. 2013 Dec 17;28(4):e398-404. doi: 10.5301/JBM.5000044.

PMID:
23873620
40.

TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy.

Roselli M, Ferroni P, Rolfo C, Peeters M, Palmirotta R, Formica V, Ludovici G, Laudisi A, De Marchis ML, La Farina F, Russo A, Guadagni F.

Ann Oncol. 2013 Oct;24(10):2571-5. doi: 10.1093/annonc/mdt251. Epub 2013 Jul 12.

PMID:
23852308
41.

Mutational analysis of gastrointestinal stromal tumors (GISTs): procedural approach for diagnostic purposes.

Palmirotta R, De Marchis ML, Ludovici G, Leone B, Covello R, Conti S, Costarelli L, Della-Morte D, Ferroni P, Roselli M, Guadagni F.

Cancer Genomics Proteomics. 2013 May-Jun;10(3):115-23.

PMID:
23741027
42.

Prion protein gene M129V polymorphism and variability in age at migraine onset.

Palmirotta R, Ludovici G, Egeo G, Ialongo C, Aurilia C, Fofi L, De Marchis ML, Della-Morte D, Barbanti P, Guadagni F.

Headache. 2013 Mar;53(3):540-5. doi: 10.1111/head.12043. Epub 2013 Feb 13.

PMID:
23405858
43.

Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence.

Roselli M, Ferroni P, Riondino S, Mariotti S, Laudisi A, Vergati M, Cavaliere F, Palmirotta R, Guadagni F.

Int J Cancer. 2013 Sep 1;133(5):1253-8. doi: 10.1002/ijc.28104. Epub 2013 Mar 16.

44.

D allele of ACE gene insertion/deletion polymorphism: a marker for risk of ischemic stroke.

Della-Morte D, Guadagni F, Palmirotta R, Ferroni P, Rundek T.

Pharmacogenomics. 2013 Jan;14(1):16. No abstract available.

PMID:
23383416
45.

Polymorphisms on IL1B and VWF genes are associated with response to fibrinolysis in Hispanics with ischemic stroke.

Della-Morte D, Guadagni F, Palmirotta R, Ferroni P, Rundek T.

Pharmacogenomics. 2013 Jan;14(1):15-6. No abstract available.

PMID:
23383415
46.

MDR1 and LPL genetic variants are associated with unfavorable outcome in stroke patients under atorvastatin treatment.

Della-Morte D, Guadagni F, Palmirotta R, Ferroni P, Rundek T.

Pharmacogenomics. 2013 Jan;14(1):14-5. No abstract available.

PMID:
23379020
47.

Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM).

Palmirotta R, Barbanti P, Ludovici G, Egeo G, Aurilia C, Fofi L, De Marchis ML, Spila A, Ferroni P, Della-Morte D, Guadagni F.

Neurol Sci. 2013 Sep;34(9):1659-63. doi: 10.1007/s10072-013-1308-x. Epub 2013 Jan 26.

PMID:
23354611
48.

Effect of GRK4 genetic variants on blood pressure response to atenolol and cardiovascular outcomes.

Della-Morte D, Guadagni F, Palmirotta R, Ferroni P, Rundek T.

Pharmacogenomics. 2013 Jan;14(1):13-4. doi: 10.2217/pgs.12.184. No abstract available.

PMID:
23252944
49.

Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning.

Della-Morte D, Guadagni F, Palmirotta R, Ferroni P, Testa G, Cacciatore F, Abete P, Rengo F, Perez-Pinzon MA, Sacco RL, Rundek T.

Pharmacogenomics. 2012 Nov;13(15):1741-57. doi: 10.2217/pgs.12.157. Review.

PMID:
23171338
50.

Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel Dose versus prasugrel: the RESET GENE trial.

Sardella G, Calcagno S, Mancone M, Palmirotta R, Lucisano L, Canali E, Stio RE, Pennacchi M, Di Roma A, Benedetti G, Guadagni F, Biondi-Zoccai G, Fedele F.

Circ Cardiovasc Interv. 2012 Oct;5(5):698-704. doi: 10.1161/CIRCINTERVENTIONS.112.972463. Epub 2012 Oct 9.

Supplemental Content

Loading ...
Support Center